The Door To Unloading with IMPELLA CP Pivotal Study

Brief description of study

The purpose of this research study is to evaluate whether using the Study Device System (a temporary circulatory assist device) before the catheterization procedure has the potential to reduce the damage to your heart caused by a heart attack compared to the current standard of care (a catheterization procedure). The Study Device has been approved by the FDA for commercial use in the United States to treat patients with different conditions than yours, and who need assistance pumping blood from the heart to the rest of the body, for up to four (4) days. The Study Device, when used in this study, will likely be used for four (4) to six (6) hours.

Clinical Study Identifier: s19-00977 Identifier: NCT03947619

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.